Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Annovis Bio, Inc. (ANVS) had Income from Continuous Operations of $-7.26M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-7.26M |
|
-- |
|
-- |
|
$7.43M |
|
$-7.43M |
|
$0.17M |
|
$-7.26M |
|
$-7.26M |
|
$-7.26M |
|
|
Income from Continuous Operations |
$-7.26M |
$-7.26M |
|
$-7.26M |
|
$-7.43M |
|
$-7.43M |
|
19.69M |
|
19.69M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$17.19M |
|
-- |
|
-- |
|
$17.19M |
|
$3.73M |
|
-- |
|
$0.30M |
|
$4.03M |
|
$13.16M |
|
$13.16M |
|
$13.16M |
|
20.19M |
|
| Cash Flow Statement Financials | |
$-16.69M |
|
-- |
|
$21.43M |
|
$10.55M |
|
$15.29M |
|
$4.73M |
|
$1.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-55.20% |
|
-55.20% |
|
-42.25% |
|
-55.20% |
|
$0.65 |
|
$-0.85 |
|
$-0.85 |
|